Weighing of Evidence by Health Technology Assessment Bodies: Retrospective Study of Reimbursement Recommendations for Conditionally Approved Drugs

This study assessed whether five Health Technology Assessment (HTA) bodies in Europe were more negative about drugs with a Conditional Marketing Authorization (CMA) that are approved without controlled studies compared to CMA drugs that are approved based on controlled studies. The HTA recommendatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Vreman, Rick A., Bouvy, Jacoline C., Bloem, Lourens T., Hövels, Anke M., Mantel‐Teeuwisse, Aukje K., Leufkens, Hubert G.M., Goettsch, Wim G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587700/
https://www.ncbi.nlm.nih.gov/pubmed/30300938
http://dx.doi.org/10.1002/cpt.1251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587700/
https://www.ncbi.nlm.nih.gov/pubmed/30300938
http://dx.doi.org/10.1002/cpt.1251

Ejemplares similares